Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (7,423,742) $ (6,532,941)
Adjustments to reconcile net loss to net cash used in operating activities:    
Equity-based compensation 1,644,077 1,133,333
Non-cash warrant modification expense 441,763
Amortization of intangible assets 423 424
Changes in operating assets and liabilities:    
Prepaid research and development expenses 322,507 45,905
Prepaid expenses and other current assets (233,330) (193,332)
Accrued expenses 613,748 133,995
Accounts payable 57,196 384,977
Net cash used in operating activities (5,019,121) (4,585,876)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from sale of common stock and warrants 5,157,215 8,195,673
Proceeds from warrant exercise 450,008 1,050,841
Net cash provided by financing activities 5,607,223 9,246,514
NET INCREASE IN CASH AND CASH EQUIVALENTS 588,102 4,660,638
CASH AND CASH EQUIVALENTS-BEGINNING OF PERIOD 6,777,052 3,869,043
CASH AND CASH EQUIVALENTS-END OF PERIOD 7,365,154 8,529,681
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest paid
Income taxes paid
Reclassification of stock-based comp from accrued expenses $ 117,001